Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultra-early vs early tirofiban after IV thrombolysis in non-cardioembolic acute ischemic stroke
ChiCTR2500106176Phase 4Not yet recruiting
- Sponsor
- Army Medical Center of PLA
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tirofiban in brain infarction (2 arms), sponsored by Army Medical Center of PLA. Primary endpoints: symptomatic intracranial hemorrhage, change of NIHSS at 24 hours post rt-PA and 1 more. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
tirofiban
03
Conditions
brain infarction
Beyond the preview
Go deeper on ChiCTR2500106176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106176.